BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3511406)

  • 21. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    Brown ES; Gorman AR; Hynan LS
    J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in the carotid atheromatous plaques and in flow conditions in patients with cerebrovascular pathology after treatment with CDP choline. Clinico-instrumental study].
    Bellagamba G; Gentili G; Caratelli L; Balestrini F; Fratalocchi N; Assouad C; Moretti V; Dragonetti G; Evangelisti A; Salvolini U
    Minerva Cardioangiol; 1984; 32(7-8):483-8. PubMed ID: 6387537
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic effects of cyticholine (cytidine-diphospho-choline) in Parkinsonian syndrome].
    Ruggieri S; Zamponi A; Casacchia M; Agnoli A
    Clin Ter; 1976 Sep; 78(6):515-25. PubMed ID: 797506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of mild cognitive impairment: value of citicoline].
    Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
    Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombocytopenia secondary to citicholine].
    Marcos Sánchez F; Juárez Ucelay F; Aguirre de Cárcer A; Moreiras Jiménez JL
    Med Clin (Barc); 1987 Apr; 88(16):653. PubMed ID: 3600074
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recognan therapy of motor disturbances in patients with stroke].
    Lebedeva NV; Lunev DK; Shvedkov VV; Solov'ev OI; Smirnova IN; Altunina MN
    Klin Med (Mosk); 1991 Nov; 69(11):83-4. PubMed ID: 1808420
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].
    Serra F; Diaspri GP; Gasbarrini A; Giancane S; Rimondi A; Tamè MR; Sakellaridis E; Bernardi M; Gasbarrini G
    Minerva Med; 1990 Jun; 81(6):465-70. PubMed ID: 2193245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.
    Warach S; Pettigrew LC; Dashe JF; Pullicino P; Lefkowitz DM; Sabounjian L; Harnett K; Schwiderski U; Gammans R
    Ann Neurol; 2000 Nov; 48(5):713-22. PubMed ID: 11079534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
    Clark WM; Warach SJ; Pettigrew LC; Gammans RE; Sabounjian LA
    Neurology; 1997 Sep; 49(3):671-8. PubMed ID: 9305321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citicoline: pharmacological and clinical review, 2010 update.
    Secades JJ
    Rev Neurol; 2011 Mar; 52 Suppl 2():S1-S62. PubMed ID: 21432836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
    Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
    Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment.
    Salvadorini F; Galeone F; Nicotera M; Ombrato M; Saba P
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):513-20. PubMed ID: 810312
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is it possible to improve erythrocyte deformability in vascular diseases in the aged? Preliminary study].
    Crolle G; Cucca S; Gosparini B; Baso G; Martechini A; Urbani N; Vattolo S
    Minerva Med; 1985 Jul; 76(28-29):1349-51. PubMed ID: 3895045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride].
    Ciuffetti G; Mercuri M; Lombardini R; Palazzetti D; Rizzo MT; Parnetti L
    Minerva Med; 1989 Nov; 80(11):1237-40. PubMed ID: 2689916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citicoline improves memory performance in elderly subjects.
    Alvarez XA; Laredo M; Corzo D; Fernández-Novoa L; Mouzo R; Perea JE; Daniele D; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):201-10. PubMed ID: 9203170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicoline.
    Bolland K; Whitehead J; Cobo E; Secades JJ
    Pharm Stat; 2009; 8(2):136-49. PubMed ID: 18637642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
    Conant R; Schauss AG
    Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
    Minerva Med; 1978 Jun; 69(31):2095-113. PubMed ID: 351463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.